These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 29288700)

  • 1. Erythrosin B is a potent and broad-spectrum orthosteric inhibitor of the flavivirus NS2B-NS3 protease.
    Li Z; Sakamuru S; Huang R; Brecher M; Koetzner CA; Zhang J; Chen H; Qin CF; Zhang QY; Zhou J; Kramer LD; Xia M; Li H
    Antiviral Res; 2018 Feb; 150():217-225. PubMed ID: 29288700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease.
    Brecher M; Li Z; Liu B; Zhang J; Koetzner CA; Alifarag A; Jones SA; Lin Q; Kramer LD; Li H
    PLoS Pathog; 2017 May; 13(5):e1006411. PubMed ID: 28542603
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists.
    Shiryaev SA; Farhy C; Pinto A; Huang CT; Simonetti N; Elong Ngono A; Dewing A; Shresta S; Pinkerton AB; Cieplak P; Strongin AY; Terskikh AV
    Antiviral Res; 2017 Jul; 143():218-229. PubMed ID: 28461069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Existing drugs as broad-spectrum and potent inhibitors for Zika virus by targeting NS2B-NS3 interaction.
    Li Z; Brecher M; Deng YQ; Zhang J; Sakamuru S; Liu B; Huang R; Koetzner CA; Allen CA; Jones SA; Chen H; Zhang NN; Tian M; Gao F; Lin Q; Banavali N; Zhou J; Boles N; Xia M; Kramer LD; Qin CF; Li H
    Cell Res; 2017 Aug; 27(8):1046-1064. PubMed ID: 28685770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Role of Flavivirus NS2B-NS3 Proteases in Viral Pathogenesis and Anti-flavivirus Drug Discovery Employing Animal Cells and Models: A Review.
    Wahaab A; Mustafa BE; Hameed M; Stevenson NJ; Anwar MN; Liu K; Wei J; Qiu Y; Ma Z
    Viruses; 2021 Dec; 14(1):. PubMed ID: 35062249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-active carbazole derivatives as inhibitors of the zika virus protease.
    Rassias G; Zogali V; Swarbrick CMD; Ki Chan KW; Chan SA; Gwee CP; Wang S; Kaplanai E; Canko A; Kiousis D; Lescar J; Luo D; Matsoukas MT; Vasudevan SG
    Eur J Med Chem; 2019 Oct; 180():536-545. PubMed ID: 31344613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylene blue is a potent and broad-spectrum inhibitor against Zika virus
    Li Z; Lang Y; Sakamuru S; Samrat S; Trudeau N; Kuo L; Rugenstein N; Tharappel A; D'Brant L; Koetzner CA; Hu S; Zhang J; Huang R; Kramer LD; Butler D; Xia M; Li H
    Emerg Microbes Infect; 2020 Dec; 9(1):2404-2416. PubMed ID: 33078696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The GA-Hecate Peptide inhibits the ZIKV Replicative Cycle in Different Steps and can Inhibit the Flavivirus NS2B-NS3 Protease after Cell Infection.
    da Silva Sanches PR; de Campos Faria JCE; Bittar C; Guberovich Olivieri HAS; de Moraes Roso Mesquita NC; Noske GD; de Godoy AS; Oliva G; Rahal P; Cilli EM
    Protein Pept Lett; 2024; 31(7):532-543. PubMed ID: 39039677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural Insights into the Inhibition of Zika Virus NS2B-NS3 Protease by a Small-Molecule Inhibitor.
    Li Y; Zhang Z; Phoo WW; Loh YR; Li R; Yang HY; Jansson AE; Hill J; Keller TH; Nacro K; Luo D; Kang C
    Structure; 2018 Apr; 26(4):555-564.e3. PubMed ID: 29526431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards the design of antiviral inhibitors against flaviviruses: the case for the multifunctional NS3 protein from Dengue virus as a target.
    Lescar J; Luo D; Xu T; Sampath A; Lim SP; Canard B; Vasudevan SG
    Antiviral Res; 2008 Nov; 80(2):94-101. PubMed ID: 18674567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of ten NS2B-NS3 proteases: Paving the way for pan-flavivirus drugs.
    Voss S; Rademann J; Nitsche C
    Antiviral Res; 2024 Jun; 226():105878. PubMed ID: 38582134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SAR evolution towards potent C-terminal carboxamide peptide inhibitors of Zika virus NS2B-NS3 protease.
    Colarusso S; Ferrigno F; Ponzi S; Pavone F; Conte I; Abate L; Beghetto E; Missineo A; Amaudrut J; Bresciani A; Paonessa G; Tomei L; Montalbetti C; Bianchi E; Toniatti C; Ontoria JM
    Bioorg Med Chem; 2022 Mar; 57():116631. PubMed ID: 35123179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Zika virus NS2B-NS3 protease and NS5 polymerase inhibitors by structure-based virtual screening of FDA-approved drugs.
    Ezzemani W; Altawalah H; Windisch M; Ouladlahsen A; Saile R; Kettani A; Ezzikouri S
    J Biomol Struct Dyn; 2024 Sep; 42(15):8073-8088. PubMed ID: 37528667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viperin Restricts Zika Virus and Tick-Borne Encephalitis Virus Replication by Targeting NS3 for Proteasomal Degradation.
    Panayiotou C; Lindqvist R; Kurhade C; Vonderstein K; Pasto J; Edlund K; Upadhyay AS; Överby AK
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Inhibition of NS2B/NS3 Protease: A New Therapeutic Opportunity to Treat Dengue and Zika Virus Infection.
    Starvaggi J; Previti S; Zappalà M; Ettari R
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and enzymatic characterization of NS2B-NS3 protease of Alkhurma virus, a class-4 flavivirus.
    Bessaud M; Grard G; Peyrefitte CN; Pastorino B; Rolland D; Charrel RN; de Lamballerie X; Tolou HJ
    Virus Res; 2005 Jan; 107(1):57-62. PubMed ID: 15567034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies Towards Protease Inhibitors for Emerging Flaviviruses.
    Nitsche C
    Adv Exp Med Biol; 2018; 1062():175-186. PubMed ID: 29845533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting the NS2B-NS3 protease of tick-borne encephalitis virus with pan-flaviviral protease inhibitors.
    Akaberi D; Båhlström A; Chinthakindi PK; Nyman T; Sandström A; Järhult JD; Palanisamy N; Lundkvist Å; Lennerstrand J
    Antiviral Res; 2021 Jun; 190():105074. PubMed ID: 33872674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The flavivirus NS2B-NS3 protease-helicase as a target for antiviral drug development.
    Luo D; Vasudevan SG; Lescar J
    Antiviral Res; 2015 Jun; 118():148-58. PubMed ID: 25842996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, structure-activity relationship and antiviral activity of indole-containing inhibitors of Flavivirus NS2B-NS3 protease.
    Nie S; Zhao J; Wu X; Yao Y; Wu F; Lin YL; Li X; Kneubehl AR; Vogt MB; Rico-Hesse R; Song Y
    Eur J Med Chem; 2021 Dec; 225():113767. PubMed ID: 34450494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.